Diagnostic News and Research

RSS

NCCN Guidelines for breast cancer does not recommend prophylactic mastectomy in women

Despite a recent study finding that an increasing number of women who had cancer in one breast are opting to have the other breast removed, the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology(TM) for Breast Cancer discourages prophylactic mastectomy in women except for those considered high risk.

29 Oct 2009

Cordis recalls its CROSSOVER Sheath Introducer

Cordis Corporation announced today a nationwide voluntary recall of all lots of the CROSSOVER™ Sheath Introducer due to complaints about stretching or fracture of the sheath during use.

29 Oct 2009

AMT inks agreement with Progenika Biopharma for development of LPLchip

Amsterdam Molecular Therapeutics (AMT) and Progenika Biopharma announced today that the companies have entered into a development and commercialization agreement for LPLchip(TM), a diagnostic tool to rapidly diagnose patients with complete and partial lipoprotein lipase deficiency (LPLD). AMT has developed Glybera(R) as a gene therapy for patients with this disease.

29 Oct 2009

Impact of wellness programs on pharmaceutical, diagnostic and device markets

MarketResearch.com has announced the addition of Kalorama Information's new report, "The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets," to their collection of Healthcare market reports.

29 Oct 2009

Inpatient diagnostic imaging exams achieve lower in-hospital mortality rates, shows study

Hospitals that make greater use of inpatient diagnostic imaging exams achieve lower in-hospital mortality rates with little or no impact on costs, according to a peer-reviewed study of more than 1 million patient outcomes in more than 100 hospitals nationwide published in the November issue of the Journal of the American College of Radiology (JACR).

29 Oct 2009

Biomoda to launch multisite Phase III clinical trials of CyPath assay

Medical diagnostics company Biomoda, Inc. is taking preliminary steps to launch multisite Phase III clinical trials of its in-vitro diagnostic for early-stage lung cancer, trademarked under the name CyPath®.

29 Oct 2009

Berkeley HeartLab enters into collaborative agreement

Berkeley HeartLab (BHL), a subsidiary of Celera Corporation, announced today that it has entered into collaborative agreements with Geisinger Medical Center and Proven Diagnostics, a clinical laboratory service recently launched by Geisinger Health System.

29 Oct 2009

U.S. Department of Defense funds Rush University Medical Center for gastrointestinal microorganism research

The human body contains billions of microorganisms, and microbial cells found in the human gut are estimated to outnumber human cells by ten-to-one in healthy adults. However, little is known about the ways in which these minute life forms influence health and disease.

28 Oct 2009

Avisio signs agreement to commercialize Instant Detect diagnostic technology

Avisio, Inc. announces the signing of a definitive agreement to commercialize Instant Detect, a portable nano-based diagnostic technology. Avisio, a publicly-traded commercialization company with a mission to unlock the value of high-potential assets and transform them into high-value businesses, now has the worldwide license to commercialize Instant Detect's ground-breaking portable diagnostic sensory technology.

28 Oct 2009

Modern functional brain imaging techniques can be a dynamic process of looking at psychopathology

Modern functional brain imaging techniques are available to psychiatrists and are promising modern-day 'telescopes' to explore in vivo brain activity. Modern psychiatric neuroimaging suggests that only phenomena that may be seen and mathematically computed throughout the scan are real.

28 Oct 2009

Pure Protein develops soluble Class II human leukocyte antigens

Pure Protein, L.L.C., a biopharmaceutical company specializing in diagnostic and therapeutic reagents for use in immunology research and development, has announced that Chief Scientist William Hildebrand, Ph.D., and his team, have developed soluble Class II human leukocyte antigens (HLA). This represents a significant technology breakthrough that can dramatically impact multiple pharmaceutical and medical sectors and has enormous market potential. Autoimmune disease is a key area of interest for HLA research and product development.

28 Oct 2009

Micronics inks license agreement with Biosearch Technologies

Micronics, Inc., a leading developer of point-of-care molecular diagnostic products, announced today that it has entered into a license agreement with Biosearch Technologies, Inc. (Biosearch) for the right to make, have made, use and sell Micronics’ products that incorporate Biosearch’s proprietary fluorophores and quencher dyes for nucleic acid assays. Under the terms of the worldwide license, Biosearch has granted Micronics a royalty-free use of certain of its chemistries for inclusion in Micronics’ infectious disease tests for sale in underdeveloped countries.

28 Oct 2009

DSM Biomedical announces new non-biofouling coating technology for medical applications

DSM Biomedical, a global leader in biomedical materials, today announced the development of VitroStealth™, a breakthrough non-biofouling (NBF) coating technology. Specifically developed to combine state of the art non-biofouling properties with high durability and fast processing, VitroStealth™ coating is scratch resistant and reduces unwanted protein absorption and cellular adhesion on surfaces.

28 Oct 2009

Biomerica moves to new Corporate, R&D and manufacturing facility in Irvine, California

Biomerica, Inc., a global provider of advanced diagnostic products for the early detection of medical conditions, today announced their move to a new Corporate, R&D and Manufacturing facility in Irvine, California.

28 Oct 2009

MolecularMD moves core operations to expanded facility

MolecularMD Corp announced today that it has moved their core operations to a expanded dedicated facility with capacity and functionality to support the expansion of its cancer molecular diagnostics business.

28 Oct 2009

Annual general meeting of shareholders to be held by China Medical Technologies

China Medical Technologies, Inc. (the "Company"), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company will hold its annual general meeting of shareholders at the Company's office at 24 Yong Chang North Road, Beijing Economic-Technological Development Area, Beijing 100176, the People's Republic of China on November 16, 2009 at 9:00 a.m., local time.

28 Oct 2009

Ascent Healthcare Solutions to reprocess the SoundStar 3D Diagnostic Ultrasound Catheter

Ascent Healthcare Solutions, a leader in delivering healthcare resource sustainability, today announced that it has received the industry’s first and only 510(k) clearance from the U.S. Food and Drug Administration (FDA) to reprocess the Biosense Webster SoundStar™ 3D Diagnostic Ultrasound Catheter. With this new clearance, Ascent continues to lead the charge in bringing sustainability to healthcare.

28 Oct 2009

Simbionix launches advanced simulator for GI endoscopy and flexible bronchoscopy training

Simbionix, the world's leading developer of medical simulation systems, introduces it's new advanced simulator, the GI-BRONCH Mentor, a comprehensive solution for virtual reality training of GI Endoscopy and Flexible Bronchoscopy.

28 Oct 2009

Toshiba America Medical Systems launches new Infinix VF-i/BP vascular X-ray system

Increasing the flexibility and diagnostic capabilities in bi-plane vascular X-ray imaging, Toshiba America Medical Systems, Inc. introduces the all new Infinix™ VF-i/BP with large and mid-sized flat panel detectors. The large and mid-sized flat panel detectors provide clinicians with the ability to obtain critical variations in angle combinations while providing the necessary anatomical coverage, creating the optimal universal bi-plane vascular X-ray system for any clinical application.

28 Oct 2009

Vascular surgeons are endovascularly-trained and have better safety records

Vascular surgeons have the highest market share and the lowest overall mortality and morbidity rates for peripheral arterial interventions (PAI), when compared to interventional cardiologists and interventional radiologists who also perform this procedure.

28 Oct 2009

Diagnostic News and Research

NCCN Guidelines for breast cancer does not recommend prophylactic mastectomy in women

Cordis recalls its CROSSOVER Sheath Introducer

AMT inks agreement with Progenika Biopharma for development of LPLchip

Impact of wellness programs on pharmaceutical, diagnostic and device markets

Inpatient diagnostic imaging exams achieve lower in-hospital mortality rates, shows study

Biomoda to launch multisite Phase III clinical trials of CyPath assay

Berkeley HeartLab enters into collaborative agreement

U.S. Department of Defense funds Rush University Medical Center for gastrointestinal microorganism research

Avisio signs agreement to commercialize Instant Detect diagnostic technology

Modern functional brain imaging techniques can be a dynamic process of looking at psychopathology

Pure Protein develops soluble Class II human leukocyte antigens

Micronics inks license agreement with Biosearch Technologies

DSM Biomedical announces new non-biofouling coating technology for medical applications

Biomerica moves to new Corporate, R&D and manufacturing facility in Irvine, California

MolecularMD moves core operations to expanded facility

Annual general meeting of shareholders to be held by China Medical Technologies

Ascent Healthcare Solutions to reprocess the SoundStar 3D Diagnostic Ultrasound Catheter

Simbionix launches advanced simulator for GI endoscopy and flexible bronchoscopy training

Toshiba America Medical Systems launches new Infinix VF-i/BP vascular X-ray system

Vascular surgeons are endovascularly-trained and have better safety records

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News